文献速递腹部技术与安全CT

基于CT的影像组学列线图术前预测结直肠癌BRAF突变及临床结局:双中心研究

Computed tomography-based radiomics nomogram for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer: a double-center study.
PubMed 文献 · Br J Radiol · 2023-05-17

该双中心回顾性研究纳入451例结直肠癌患者,构建基于CT的影像组学列线图(Radscore联合年龄、肿瘤位置和cN分期),在训练集、内部验证集和外部验证集中预测BRAF突变的AUC分别为0.86、0.82和0.82,且列线图预测的高风险组总生存期更差。

要点

  • CT影像组学列线图可术前预测结直肠癌BRAF突变,外部验证AUC为0.82。
  • 列线图预测的BRAF突变高风险组总生存期显著更差(p<0.0001)。
  • 列线图整合了Radscore与年龄、肿瘤位置、cN分期等临床独立预测因子。

核心结论

  • 基于CT的影像组学列线图在预测结直肠癌BRAF突变和总生存期方面表现良好,可为个体化治疗提供有价值的信息。
  • 列线图预测的BRAF突变高风险组与较差的总生存期独立相关。

研究设计与样本

  • 双中心回顾性研究,共纳入451例结直肠癌患者,分为训练集190例、内部验证集125例和外部验证集136例。
  • 采用最小绝对收缩和选择算子回归筛选影像组学特征并计算Radscore,结合Radscore和显著临床预测因子构建列线图。
  • 使用受试者工作特征曲线分析、校准曲线和决策曲线分析评估列线图的预测性能,基于列线图的Kaplan-Meier生存曲线评估总生存期。

关键影像表现/征象

  • Radscore由9个与BRAF突变最相关的影像组学特征组成。

诊断标准与关键数值

  • 列线图整合Radscore和临床独立预测因子(年龄、肿瘤位置和cN分期)。
  • 列线图在训练集、内部验证集和外部验证集中预测BRAF突变的AUC分别为0.86(95%CI:0.80-0.91)、0.82(95%CI:0.74-0.90)和0.82(95%CI:0.75-0.90)。
  • 列线图性能显著优于临床模型(p<0.05)。

临床应用与阅片要点

  • 术前CT影像组学列线图可用于结直肠癌BRAF突变风险分层,辅助个体化治疗决策。
  • 列线图预测的BRAF突变高风险组总生存期更差,提示需更密切随访或强化治疗。

局限性

  • 回顾性研究设计。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop and validate a radiomics nomogram based on CT for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer (CRC).

METHODS: A total of 451 CRC patients (training cohort = 190; internal validation cohort = 125; external validation cohort = 136) from 2 centers were retrospectively included. Least absolute shrinkage and selection operator regression was used to select radiomics features and the radiomics score (Radscore) was calculated. Nomogram was constructed by combining Radscore and significant clinical predictors. Receiver operating characteristic curve analysis, calibration curve and decision curve analysis were used to evaluate the predictive performance of the nomogram. Kaplan‒Meier survival curves based on the radiomics nomogram were used to assess overall survival (OS) of the entire cohort.

RESULTS: The Radscore consisted of nine radiomics features which were the most relevant to BRAF mutation. The radiomics nomogram integrating Radscore and clinical independent predictors (age, tumor location and cN stage) showed good calibration and discrimination with AUCs of 0.86 (95% CI: 0.80-0.91), 0.82 (95% CI: 0.74-0.90) and 0.82 (95% CI: 0.75-0.90) in the training cohort, internal validation and external validation cohorts, respectively. Furthermore,the performance of nomogram was significantly better than that of the clinical model (p < 0.05). The radiomics nomogram-predicted BRAF mutation high-risk group had a worse OS than the low-risk group (p < 0.0001).

CONCLUSION: The radiomics nomogram showed good performance in predicting BRAF mutation and OS of CRC patients, which could provide valuable information for individualized treatment.

ADVANCES IN KNOWLEDGE: The radiomics nomogram could effectively predict BRAF mutation and OS in patients with CRC. High-risk BRAF mutation group identified by the radiomics nomogram was independently associated with poor OS.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Li, Xu, Zhou, et al. Computed tomography-based radiomics nomogram for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer: a double-center study. Br J Radiol. 2023. PMID: 37195006. doi:10.1259/bjr.20230019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。